These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 717508)

  • 41. Comparison of ophthalmic bioavailability of two dexamethasone derivatives in proprietary preparations.
    Morton DJ; Flint GR
    Cent Afr J Med; 1985 Feb; 31(2):32-4. PubMed ID: 3839168
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of PF-04217329 a prodrug of a selective prostaglandin EP(2) agonist on intraocular pressure in preclinical models of glaucoma.
    Prasanna G; Carreiro S; Anderson S; Gukasyan H; Sartnurak S; Younis H; Gale D; Xiang C; Wells P; Dinh D; Almaden C; Fortner J; Toris C; Niesman M; Lafontaine J; Krauss A
    Exp Eye Res; 2011 Sep; 93(3):256-64. PubMed ID: 21376717
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The ocular penetration of topical forskolin and its effects on intraocular pressure, aqueous flow rate and cyclic AMP level in the rabbit eye.
    Matsumoto S; Yamashita T; Araie M; Kametani S; Hosokawa T; Takase M
    Jpn J Ophthalmol; 1990; 34(4):428-35. PubMed ID: 1964483
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Absence of an effect of topical dexamethasone on endothelial permeability and flow of aqueous humor.
    Rice SW; Bourne WM; Brubaker RF
    Invest Ophthalmol Vis Sci; 1983 Sep; 24(9):1307-11. PubMed ID: 6885315
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optimal frequency of topical prednisolone administration.
    Leibowitz HM; Kupferman A
    Arch Ophthalmol; 1979 Nov; 97(11):2154-6. PubMed ID: 508185
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dexamethasone Disodium Phosphate Penetration Into the Human Aqueous Humor After Topical Application.
    Cagini C; Cometa F; Torroni G; Pellegrino A; Pellegrino R; Cavallini GM
    Curr Eye Res; 2016 Jul; 41(7):897-9. PubMed ID: 26580978
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Arachidonic acid-induced elevation of intraocular pressure and anti-inflammatory agents.
    Conquet P; Plazonnet B; Le Douarec JC
    Invest Ophthalmol; 1975 Oct; 14(10):772-5. PubMed ID: 1184310
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of mifepristone on rabbit intraocular pressure in the presence and absence of dexamethasone.
    Green K; Cheeks L; Slagle T; Phillips CI
    Ophthalmic Res; 1990; 22(4):247-52. PubMed ID: 2089341
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Management of inflammation in the cornea and conjunctiva.
    Leibowitz HM
    Ophthalmology; 1980 Aug; 87(8):753-8. PubMed ID: 7443202
    [TBL] [Abstract][Full Text] [Related]  

  • 50. AL-2512, a novel corticosteroid: preclinical assessment of anti-inflammatory and ocular hypertensive effects.
    Bhattacherjee P; Mukhopadhyay P; Paterson CA; Graff G; Gamache DA; Yanni JM
    J Ocul Pharmacol Ther; 2003 Aug; 19(4):353-60. PubMed ID: 12964959
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ocular penetration studies. I. Topical administration of dexamethasone.
    Short C; Keates RH; Donovan EF; Wyman M; Murdick PW
    Arch Ophthalmol; 1966 May; 75(5):689-92. PubMed ID: 5936375
    [No Abstract]   [Full Text] [Related]  

  • 52. Supramolecular nanofibers of dexamethasone derivatives to form hydrogel for topical ocular drug delivery.
    Zhang Z; Yu J; Zhou Y; Zhang R; Song Q; Lei L; Li X
    Colloids Surf B Biointerfaces; 2018 Apr; 164():436-443. PubMed ID: 29438842
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of dehydroepiandrosterone on rabbit intraocular pressure.
    Kearse EC; McIntyre OL; Johnson MH; Phillips CI; Lathe R; Adams W; Green K
    Ophthalmic Res; 2001; 33(1):42-7. PubMed ID: 11114604
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of suprofen on corneal wound healing.
    Lee BP; Kupferman A; Leibowitz HM
    Arch Ophthalmol; 1985 Jan; 103(1):95-7. PubMed ID: 3977682
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intraocular fate of dexamethasone disodium phosphate topically applied to the eyes of rabbits.
    Ichigashira N; Yamaga N
    Steroids; 1978 Dec; 32(5):615-28. PubMed ID: 734696
    [TBL] [Abstract][Full Text] [Related]  

  • 56. L-662,583 is a topically effective ocular hypotensive carbonic anhydrase inhibitor in experimental animals.
    Sugrue MF; Gautheron P; Mallorga P; Nolan TE; Graham SL; Schwam H; Shepard KL; Smith RL
    Br J Pharmacol; 1990 Jan; 99(1):59-64. PubMed ID: 2110013
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aqueous Humor Penetration and Biological Activity of Moxifloxacin 0.5% Ophthalmic Solution Alone or with Dexamethasone 0.1.
    Gomes RL; Viana RG; Melo LA; Cruz AC; Suenaga EM; Kenyon KR; Campos M
    J Ocul Pharmacol Ther; 2017 Mar; 33(2):98-102. PubMed ID: 28231036
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Topical dexamethasone lowers rabbit ocular tension, as does topical mifepristone (RU 486), a peripheral blocker of dexamethasone and progesterone.
    Phillips CI; Peat K; Gore SM; Clark CV; Clark M; Mackintosh GI; Green K
    Ophthalmic Res; 1989; 21(3):235-8. PubMed ID: 2779976
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ocular surface distribution and pharmacokinetics of a novel ophthalmic 1% azithromycin formulation.
    Akpek EK; Vittitow J; Verhoeven RS; Brubaker K; Amar T; Powell KD; Boyer JL; Crean C
    J Ocul Pharmacol Ther; 2009 Oct; 25(5):433-9. PubMed ID: 19857105
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A nanoparticle formulation of disulfiram prolongs corneal residence time of the drug and reduces intraocular pressure.
    Nagai N; Yoshioka C; Mano Y; Tnabe W; Ito Y; Okamoto N; Shimomura Y
    Exp Eye Res; 2015 Mar; 132():115-23. PubMed ID: 25633346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.